Montelukast
Product Images NDC 63629-4886

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast (NDC 63629-4886). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Montelukast 01

Montelukast 01
A line graph depicting change in height (cm) over weeks of treatment comparing Montelukast 5 mg, Beclomethasone 336 mcg, and placebo groups. The x-axis shows weeks on treatment from -19 to 60, and the y-axis shows height change from -3 to 7 cm. Three lines represent each treatment group's height change trends over time.*
FDA Label Image

Lbl636294886

Lbl636294886
Montelukast Sodium 10 mg tablet label from Bryant Ranch Prepack. The label indicates it is a brown round tablet, package contains 30 tablets, and compares to Singulair 10 mg tablet by Sandoz Inc. Includes storage instructions to keep tightly closed and store at 20°-25°C (68°-77°F). NDC 63629-4886 is present along with a barcode.*
FDA Label Image

Montelukast 02

Montelukast 02
Chemical structure of Montelukast, showing its molecular arrangement including a chlorine-substituted quinoline ring, a cyclopropane carboxylate group, and hydroxyl and isopropyl substituents.*
FDA Label Image

Montelukast 03

Montelukast 03
A line graph showing mean percent change from baseline over weeks in treatment for two groups: placebo and Montelukast. The x-axis represents weeks in treatment from 0 to 15, and the y-axis shows mean percent change from 0 to 15. Montelukast group data points are connected by a solid line with filled circles, while placebo group data points use open squares. The graph includes error bars and indicates a washout period after week 12 with a dashed line for Montelukast.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.